Luteolin impacts deoxyribonucleic acid repair by modulating the mitogen-activated protein kinase pathway in colorectal cancer

References

• Cao W, Chen H-D, Yu Y-W, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134(7):783–791.
   PubMed Web of Science ®Google Scholar
• De Rosa M, Pace U, Rega D, et al. Genetics, diagnosis and management of colorectal cancer (Review). Oncol Rep. 2015;34:1087–1096.
   PubMed Web of Science ®Google Scholar
• Sharma R. An examination of colorectal cancer burden by socioeconomic status: evidence from GLOBOCAN 2018. EPMA J. 2020;11:95–117.
   PubMed Web of Science ®Google Scholar
• Graff RE, Moller S, Passarelli MN, et al. Familial risk and heritability of colorectal cancer in the Nordic twin study of cancer. Clin Gastroenterol Hepatol. 2017;15:1256–1264.
   PubMed Web of Science ®Google Scholar
• Nussbaum YI, Manjunath Y, Suvilesh KN, et al. Current and prospective methods for assessing Anti-Tumor immunity in colorectal cancer. Int J Mol Sci. 2021;22:4802.
   PubMed Web of Science ®Google Scholar
• Snyder RA, Hu CY, Zafar SN, et al. Racial disparities in recurrence and overall survival in patients with locoregional colorectal cancer. J Natl Cancer Inst. 2021;113:770–777.
   PubMedGoogle Scholar
• Lo S, Leung E, Fedrizzi B, et al. Syntheses of mono-acylated luteolin derivatives, evaluation of their antiproliferative and radical scavenging activities and implications on their oral bioavailability. Sci Rep. 2021;11:12595.
   PubMed Web of Science ®Google Scholar
• Hussain Y, Cui JH, Khan H, et al. Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition. Med Oncol. 2021;38:66.
   PubMed Web of Science ®Google Scholar
• Theoharides TC. Luteolin: the wonder flavonoid. BioFactors. 2021;47:139–140.
   PubMed Web of Science ®Google Scholar
• Gong B, Zheng Y, Li J, et al. Luteolin activates M2 macrophages and suppresses M1 macrophages by upregulation of hsa_circ_0001326 in THP-1 derived macrophages. Bioengineered. 2022;13:5079–5090.
   PubMed Web of Science ®Google Scholar
• Mittra B, Saha A, Chowdhury AR, et al. Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis. Mol Med. 2000;6:527–541.
   PubMed Web of Science ®Google Scholar
• Dellafiora L, Mena P, Del Rio D, et al. Modeling the effect of phase II conjugations on topoisomerase I poisoning: pilot study with luteolin and quercetin. J Agric Food Chem. 2014;62:5881–5886.
   PubMed Web of Science ®Google Scholar
• Imran M, Rauf A, Abu-Izneid T, et al. Luteolin, a flavonoid, as an anticancer agent: a review. Biomed Pharmacothe. 2019;112:108612.
   PubMed Web of Science ®Google Scholar
• Ganai SA, Sheikh FA, Baba ZA, et al. Anticancer activity of the plant flavonoid luteolin against preclinical models of various cancers and insights on different signalling mechanisms modulated. Phytother Res. 2021;35: 3509–3532.
   PubMed Web of Science ®Google Scholar
• Shi ML, Chen YF, Wu WQ, et al. Luteolin inhibits the proliferation, adhesion, migration and invasion of choroidal melanoma cells in vitro. Exp Eye Res. 2021;210:108643.
   PubMed Web of Science ®Google Scholar
• Masraksa W, Tanasawet S, Hutamekalin P, et al. Luteolin attenuates migration and invasion of lung cancer cells via suppressing focal adhesion kinase and non-receptor tyrosine kinase signaling pathway. Nutr Res Pract. 2020;14:127–133.
   PubMed Web of Science ®Google Scholar
• Ren LQ, Li Q, Zhang Y. Luteolin suppresses the proliferation of gastric cancer cells and acts in synergy with oxaliplatin. Biomed Res Int. 2020;2020:9396512.
   PubMed Web of Science ®Google Scholar
• Wang TT, Wang SK, Huang GL, et al. Luteolin induced-growth inhibition and apoptosis of human esophageal squamous carcinoma cell line Eca109 cells in vitro. Asian Pac J Cancer Prev. 2012;13:5455–5461.
   PubMed Web of Science ®Google Scholar
• Lim W, Yang C, Bazer FW, et al. Luteolin inhibits proliferation and induces apoptosis of human placental choriocarcinoma cells by blocking the PI3K/AKT pathway and regulating sterol regulatory element binding protein activity. Biol Reprod. 2016;95:82.
   PubMed Web of Science ®Google Scholar
• Ahmed S, Khan H, Fratantonio D, et al. Apoptosis induced by luteolin in breast cancer: mechanistic and therapeutic perspectives. Phytomedicine. 2019;59:152883.
   PubMed Web of Science ®Google Scholar
• Feng XQ, Rong LW, Wang RX, et al. Luteolin and sorafenib combination kills human hepatocellular carcinoma cells through apoptosis potentiation and JNK activation. Oncol Lett. 2018;16:648–653.
   PubMed Web of Science ®Google Scholar
• Hu Y, Chen X, Li Z, et al. Thermosensitive in situ gel containing luteolin micelles is a promising efficient agent for colorectal cancer peritoneal metastasis treatment. J Biomed Nanotechnol. 2020;16:54–64.
   PubMed Web of Science ®Google Scholar
• Liu Y, Lang T, Jin B, et al. Luteolin inhibits colorectal cancer cell epithelial-to-mesenchymal transition by suppressing CREB1 expression revealed by comparative proteomics study. J Proteomics. 2017;161:1–10.
   PubMed Web of Science ®Google Scholar
• Li D, Li Q. MicroRNA-200b-3p restrains gastric cancer cell proliferation, migration, and invasion via C-X-C motif chemokine ligand 12/CXC chemokine receptor 7 axis. Bioengineered. 2022;13:6509–6520.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Hou Z, Liu W, et al. Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance. Bioengineered. 2022;13:810–823.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li X, Xu J, et al. Knockdown of nuclear receptor binding SET domain-containing protein 1 (NSD1) inhibits proliferation and facilitates apoptosis in paclitaxel-resistant breast cancer cells via inactivating the Wnt/β-catenin signaling pathway. Bioengineered. 2022;13:3526–3536.
   PubMed Web of Science ®Google Scholar
• Dong Z, Chang X, Xie L, et al. Increased expression of SRPK1 (serine/arginine-rich protein-specific kinase 1) is associated with progression and unfavorable prognosis in cervical squamous cell carcinoma. Bioengineered. 2022;13:6100–6112.
   PubMed Web of Science ®Google Scholar
• Liu X, Ma X, Li H, et al. LINC00472 suppresses oral squamous cell carcinoma growth by targeting miR-455-3p/ELF3 axis. Bioengineered. 2022;13:1162–1173.
   PubMed Web of Science ®Google Scholar
• Tong J, Lu J, Mao X, et al. Circular RNA-UBE2D2 accelerates the proliferation and metastasis of non-small cell lung cancer cells via modulating microRNA-376a-3p/Eukaryotic translation initiation factor 4γ2 axis. Bioengineered. 2022;13:5942–5953.
   PubMed Web of Science ®Google Scholar
• Chen Y, Tang X. Ultrasound targeted microbubble destruction-mediated SOCS3 attenuates biological characteristics and epithelial-mesenchymal transition (EMT) of breast cancer stem cells. Bioengineered. 2022;13:3896–3910.
   PubMed Web of Science ®Google Scholar
• Lv P, Xue Y. ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway. Bioengineered. 2021;12:3873–3885.
   PubMed Web of Science ®Google Scholar
• Yang J, Fan L, Liao X, et al. CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway. 2021;12:9377–9389.
   Google Scholar
• Maliszewska-Olejniczak K, Drozdz A, Walus M, et al. Immunofluorescence imaging of DNA damage and repair foci in human colon cancer cells. J vis exp. 2020;160.
   Google Scholar
• Chang L, Zhou R, He Y, et al. Total saponins from Rhizoma panacis Majoris inhibit proliferation, induce cell cycle arrest and apoptosis and influence MAPK signalling pathways on the colorectal cancer cell. Mol Med Rep. 2021;24:542.
   PubMed Web of Science ®Google Scholar
• Gong X, Jiang L, Li W, et al. Curcumin induces apoptosis and autophagy inhuman renal cell carcinoma cells via Akt/mTOR suppression. Bioengineered. 2021;12:5017–5027.
   PubMed Web of Science ®Google Scholar
• Wang N, Yang S, Tan T, et al. Tetrandrine suppresses the growth of human osteosarcoma cells by regulating multiple signaling pathways. Bioenginee-red. 2021;12:5870–5882.
   PubMed Web of Science ®Google Scholar
• Deng Y, Li S, Wang M, et al. Flavonoid-rich extracts from okra flowers exert antitumor activity in colorectal cancer through induction of mitochondrial dysfunction-associated apoptosis, senescence and autophagy. Food Funct. 2020;11:10448–10466.
   PubMed Web of Science ®Google Scholar
• Potocnjak I, Simic L, Gobin I, et al. Antitumor activity of luteolin in human colon cancer SW620 cells is mediated by the ERK/FOXO3a signaling pathway. Toxicol in vitro. 2020;66:104852.
   PubMed Web of Science ®Google Scholar
• Palko-Labuz A, Sroda-Pomianek K, Uryga A, et al. Anticancer activity of baicalein and luteolin studied in colorectal adenocarcinoma LoVo cells and in drug-resistant LoVo/Dx cells. Biomed Pharmacothe. 2017;88:232–241.
   PubMed Web of Science ®Google Scholar
• Jang CH, Moon N, Oh J, et al. Luteolin shifts oxaliplatin-induced cell cycle arrest at G(0)/G(1) to apoptosis in HCT116 human colorectal carcinoma cells. Nutrients. 2019;11:770.
   PubMed Web of Science ®Google Scholar
• Zuo Q, Wu R, Xiao X, et al. The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells. J Cell Biochem. 2018;119:9573–9582.
   PubMed Web of Science ®Google Scholar
• Krifa M, Leloup L, Ghedira K, et al. Luteolin induces apoptosis in BE colorectal cancer cells by downregulating calpain, UHRF1, and DNMT1 expressions. Nutr Cancer. 2014;66:1220–1227.
   PubMed Web of Science ®Google Scholar
• Leung HW, Wu CH, Lin CH, et al. Luteolin induced DNA damage leading to human lung squamous carcinoma CH27 cell apoptosis. Eur J Pharmacol. 2005;508:77–83.
   PubMed Web of Science ®Google Scholar
• Wan X, Wang C, Huang Z, et al. Cisplatin inhibits SIRT3-deacetylation MTHFD2 to disturb cellular redox balance in colorectal cancer cell. Cell Death Dis. 2020;11:649.
   PubMed Web of Science ®Google Scholar
• Al-Khayal K, Vaali-Mohammed MA, Elwatidy M, et al. A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway. BMC Cancer. 2020;20:685.
   PubMed Web of Science ®Google Scholar
• Lei L, An G, Zhu Z, et al. C8orf48 inhibits the tumorigenesis of colorectal cancer by regulating the MAPK signaling pathway. Life Sci. 2021;266:118872.
   PubMed Web of Science ®Google Scholar